Matthew Angel
President and CEO at Ernexa Therapeutics Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Ernexa Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ernexa Therapeutics Inc. June 16, 202399.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 24, 2026 | Tempest Therapeutics Inc. | Open-market purchase | +231,482 | $2.16 | $500,001 |
| Mar 24, 2026 | Tempest Therapeutics Inc. | Open-market purchase | +231,482 | $2.16 | $500,001 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.